1. Home
  2. NEXA vs SNDX Comparison

NEXA vs SNDX Comparison

Compare NEXA & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEXA
  • SNDX
  • Stock Information
  • Founded
  • NEXA 1956
  • SNDX 2005
  • Country
  • NEXA Luxembourg
  • SNDX United States
  • Employees
  • NEXA N/A
  • SNDX N/A
  • Industry
  • NEXA Metal Mining
  • SNDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEXA Basic Materials
  • SNDX Health Care
  • Exchange
  • NEXA Nasdaq
  • SNDX Nasdaq
  • Market Cap
  • NEXA 1.2B
  • SNDX 1.1B
  • IPO Year
  • NEXA 2017
  • SNDX 2016
  • Fundamental
  • Price
  • NEXA $6.38
  • SNDX $14.00
  • Analyst Decision
  • NEXA Sell
  • SNDX Strong Buy
  • Analyst Count
  • NEXA 5
  • SNDX 10
  • Target Price
  • NEXA $7.40
  • SNDX $36.20
  • AVG Volume (30 Days)
  • NEXA 297.2K
  • SNDX 2.3M
  • Earning Date
  • NEXA 02-19-2025
  • SNDX 02-25-2025
  • Dividend Yield
  • NEXA N/A
  • SNDX N/A
  • EPS Growth
  • NEXA N/A
  • SNDX N/A
  • EPS
  • NEXA N/A
  • SNDX N/A
  • Revenue
  • NEXA $2,655,440,000.00
  • SNDX $16,000,000.00
  • Revenue This Year
  • NEXA $5.82
  • SNDX N/A
  • Revenue Next Year
  • NEXA $2.31
  • SNDX N/A
  • P/E Ratio
  • NEXA N/A
  • SNDX N/A
  • Revenue Growth
  • NEXA N/A
  • SNDX N/A
  • 52 Week Low
  • NEXA $5.10
  • SNDX $12.06
  • 52 Week High
  • NEXA $9.61
  • SNDX $25.34
  • Technical
  • Relative Strength Index (RSI)
  • NEXA 37.34
  • SNDX 51.72
  • Support Level
  • NEXA $5.97
  • SNDX $12.40
  • Resistance Level
  • NEXA $6.48
  • SNDX $13.16
  • Average True Range (ATR)
  • NEXA 0.64
  • SNDX 0.69
  • MACD
  • NEXA -0.09
  • SNDX 0.19
  • Stochastic Oscillator
  • NEXA 11.61
  • SNDX 74.90

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Share on Social Networks: